Seoul Pharma Co. Ltd (018680) — Net Asset Quality Index
Seoul Pharma Co. Ltd (018680) has a Net Asset Quality Index of 55.8% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩74.00 Billion minus total liabilities of ₩32.70 Billion yields net assets of ₩41.30 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read 018680 total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Seoul Pharma Co. Ltd Net Asset Quality Index Over Time (2012–2024)
This chart shows how Seoul Pharma Co. Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 55.8%, representing net assets of ₩41.30 Billion against total assets of ₩74.00 Billion KRW. For live market cap and overall valuation, see Seoul Pharma Co. Ltd stock valuation.
Annual Net Asset Quality Index for Seoul Pharma Co. Ltd (2012–2024)
The table below presents the year-by-year Net Asset Quality Index for Seoul Pharma Co. Ltd from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check asset allocation strategy of Seoul Pharma Co. Ltd to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 56.1% | ₩40.17 Billion | ₩71.62 Billion | ₩31.45 Billion | ▼ -4.8 pp |
| 2023 | 60.9% | ₩38.56 Billion | ₩63.31 Billion | ₩24.74 Billion | ▲ +4.2 pp |
| 2022 | 56.7% | ₩35.42 Billion | ₩62.43 Billion | ₩27.01 Billion | ▲ +26.3 pp |
| 2021 | 30.5% | ₩18.96 Billion | ₩62.25 Billion | ₩43.29 Billion | ▼ -13.9 pp |
| 2020 | 44.3% | ₩28.85 Billion | ₩65.09 Billion | ₩36.23 Billion | ▲ +4.2 pp |
| 2019 | 40.1% | ₩28.45 Billion | ₩70.89 Billion | ₩42.44 Billion | ▼ -15.4 pp |
| 2018 | 55.6% | ₩50.31 Billion | ₩90.57 Billion | ₩40.25 Billion | ▼ -6.4 pp |
| 2017 | 62.0% | ₩53.86 Billion | ₩86.93 Billion | ₩33.08 Billion | ▲ +16.5 pp |
| 2016 | 45.5% | ₩42.07 Billion | ₩92.54 Billion | ₩50.47 Billion | ▲ +4.9 pp |
| 2015 | 40.6% | ₩33.53 Billion | ₩82.68 Billion | ₩49.15 Billion | ▲ +1.2 pp |
| 2014 | 39.4% | ₩31.10 Billion | ₩78.98 Billion | ₩47.88 Billion | ▼ -5.8 pp |
| 2013 | 45.2% | ₩32.25 Billion | ₩71.42 Billion | ₩39.17 Billion | ▲ +3.3 pp |
| 2012 | 41.8% | ₩25.38 Billion | ₩60.68 Billion | ₩35.29 Billion | — |